4.6 Article

Immunogenicity and protective effects of inactivated Singapore grouper iridovirus (SGIV) vaccines in orange-spotted grouper, Epinephelus coioides

Journal

DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
Volume 38, Issue 2, Pages 254-261

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.dci.2012.07.004

Keywords

Singapore grouper iridovirus (SGIV); Inactivated vaccine; Formalin; beta-propiolactone; ELISA; Immune-related genes

Funding

  1. National Basic Research Program of China (973) [2012CB114406, 2012CB114402]
  2. Natural Science Foundation of China [30800846, 30930070, 31101936]
  3. knowledge innovation program of the Chinese Academy of Sciences [KZCX2-EW-Q213, KZCX2-YW-BR-08]
  4. China Postdoctoral Science Foundation [2011M501348]

Ask authors/readers for more resources

Vaccination is one of the best methods against viral diseases. In this study, experimental inactivated Singapore grouper iridovirus (SGIV) vaccines were prepared, and immunogenicity and protection against virus infection of the vaccines were investigated in orange-spotted grouper, Epinephelus coioides. Two kinds of vaccines, including,beta-propiolactone (BPL) inactivated virus at 4 degrees C for 12 h and formalin inactivated virus at 4 degrees C for 12 d, was highly protective against the challenge at 30-day post-vaccination and produced relative percent of survival rates of 91.7% and 100%, respectively. These effective vaccinations induced potent innate immune responses mediated by pro-inflammatory cytokines and type! interferon (IFN)-stimulated genes (ISGs). It is noteworthy that ISGs, such as Mx and ISG15, were up-regulated only in the effective vaccine groups, which suggested that type 1 IFN system may be the functional basis of early anti-viral immunity. Moreover, effective vaccination also significantly up-regulated of the expression of MHC class I gene and produced substantial amount of specific serum antibody at 4 weeks post-vaccination. Taken together, our results clearly demonstrated that effective vaccination in grouper induced an early, nonspecific antiviral immunity, and later, a specific immune response involving both humoral and cell-mediated immunity. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available